Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for Primary Surgical Prevention of Breast Cancer-related Lymphedema

NCT04687956 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT04687956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04687956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for Primary Surgical Prevention of Breast Cancer-related Lymphedema
Lead sponsor
Gangnam Severance Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2021
Completion date
December 31, 2027
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lymphedema, mastectomy